9/10 June 2020
Three European Industry Associations (EFPIA, Medicines for Europe and AESGP) have published a "Call for a Mutual Recognition Agreement on Good Manufacturing Practice (GMP) in the Context of Ambitious and Comprehensive EU-UK Future Relationship Negotiations". In this paper, the associations state that "EU and UK should have the closest possible relationship for pharmaceuticals, prioritising the health of citizens and the uninterrupted supply of medicines."
They propose a pragmatic approach and hope that there "is openness at the earliest opportunity". It would be beneficial for all parties involved to come to Free Trade Agreement (FTA) as quick as possible. Such an agreement should cover:
As an example, the EU-South Korea Free Trade Agreement is named.
However immediate action is seen in completing a Mutual Recognition Agreement (MRA) on Good Manufacturing Practice (GMP). Such an agreement should cover: